Velbe
Velbe is a cancer medication that interferes with the growth and division of cancer cells.
Form
injektiokuiva-aine, liuosta varten
Strength
10 mg
Active Ingredient
Vinblastine sulfate
Manufacturer
STADA Nordic ApS
How to Use
Dosage
Your doctor will determine your individual dose.
Method
A healthcare professional will administer the Velbe injection intravenously as an infusion or a direct injection, which takes about one minute.
Important
The maximum daily dose will be determined by your doctor based on your individual treatment plan.
Possible Side Effects
COMMON
- •Decrease in white blood cell and platelet counts.
- •Hair loss.
- •Injection site irritation, skin blistering.
- •Constipation, loss of appetite, nausea, vomiting, abdominal pain, bowel obstruction, stomatitis, diarrhea, gastrointestinal bleeding.
- •High blood pressure, chest pain.
- •Bronchospasm and shortness of breath (when used with other cancer medications).
- •Bone pain, weakness, pain at the tumor site, jaw pain.
RARE
- •Sensory disturbances, depression, headache, seizures, dizziness (neurological side effects are generally rare).
- •Hearing impairment or dizziness due to auditory nerve damage (especially when used with other ototoxic cancer drugs).
- •Heart attack.
- •Hormonal disorder (antidiuretic hormone secretion) and associated sodium deficiency.
Important Warnings
- Do not use if you are allergic to vinblastine or any other ingredients.
- Do not use if you have a bacterial infection that needs to be treated first.
- Do not use if your white blood cell count is very low, unless otherwise directed by your doctor.
- Talk to your doctor if you have ischemic heart disease or liver problems.
- Inform your doctor immediately if you experience a sore throat, fever, chills, or mouth sores.
Show 3 more warnings
- Velbe is not recommended for pregnant women, women planning pregnancy, or breastfeeding women.
- Do not drive or operate machinery until you know how Velbe affects you.
- Administering Velbe into the spinal cord (intrathecally) is life-threatening and can lead to death.